Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress.

PloS One
Akira NishiyamaKeiko Ozato

Abstract

Some anti-cancer drugs, including those that alter microtubule dynamics target mitotic cells and induce apoptosis in some cell types. However, such drugs elicit protective responses in other cell types allowing cells to escape from drug-induced mitotic inhibition. Cells with a faulty protective mechanism undergo defective mitosis, leading to genome instability. Brd4 is a double bromodomain protein that remains on chromosomes during mitosis. However, Brd4 is released from mitotic chromosomes when cells are exposed to anti-mitotic drugs including nocodazole. Neither the mechanisms, nor the biological significance of drug-induced Brd4 release has been fully understood. We found that deletion of the internal C-terminal region abolished nocodazole induced Brd4 release from mouse P19 cells. Furthermore, cells expressing truncated Brd4, unable to dissociate from chromosomes were blocked from mitotic progression and failed to complete cell division. We also found that pharmacological and peptide inhibitors of the c-jun-N-terminal kinases (JNK) pathway, but not inhibitors of other MAP kinases, prevented release of Brd4 from chromosomes. The JNK inhibitor that blocked Brd4 release also blocked mitotic progression. Further supporting the ...Continue Reading

References

Jan 13, 1998·Current Opinion in Cell Biology·P K SorgerA A Hyman
Mar 4, 1998·Current Opinion in Cell Biology·M A Jordan, L Wilson
Dec 16, 1998·Science·C DongR A Flavell
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J V DunciaR E Olson
Jul 18, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M BarancíkA Breier
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·B L BennettD W Anderson
May 15, 2002·Current Biology : CB·Alexei Mikhailov, Conly L Rieder
Jun 7, 2002·Molecular Cell·Jan-Michael Peters
Jul 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anup DeyKeiko Ozato
Mar 25, 2004·Nature Cell Biology·Teiji WadaJosef M Penninger
Jul 21, 2004·The Journal of Biological Chemistry·Rebecca A MacCorkle, Tse-Hua Tan
Nov 19, 2004·Journal of Muscle Research and Cell Motility·John LimouzeJames R Sellers
Sep 16, 2006·Molecular Cell·Anja JaeschkeRoger J Davis
Nov 30, 2006·The Journal of Pharmacology and Experimental Therapeutics·Thomas J EddingerPaul H Ratz
Dec 7, 2006·The Journal of Biological Chemistry·Yoshihiro NakamuraShigeyuki Yokoyama
Dec 13, 2006·Microbiology and Molecular Biology Reviews : MMBR·Marie A Bogoyevitch, Bostjan Kobe
Feb 17, 2007·Current Opinion in Cell Biology·Claire R Weston, Roger J Davis
Mar 3, 2007·The Journal of Biological Chemistry·Shwu-Yuan Wu, Cheng-Ming Chiang
Jun 1, 2007·Molecular Carcinogenesis·Ann M Bode, Zigang Dong
Jun 22, 2007·Cell Cycle·Frank WolfStephan Geley
Aug 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dwayne A BisgroveEric Verdin
Jan 29, 2008·The Journal of Biological Chemistry·Kazuki MochizukiKeiko Ozato

❮ Previous
Next ❯

Citations

Feb 13, 2014·British Journal of Cancer·A H BeesleyU R Kees
Nov 8, 2012·Transcription·Ballachanda N Devaiah, Dinah S Singer
Jun 9, 2016·European Journal of Medicinal Chemistry·Jie LiLiang Ouyang
Apr 23, 2013·Current Opinion in Virology·Horng-Shen ChenPaul M Lieberman
Oct 19, 2017·Development·Nicola FestucciaPablo Navarro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis